Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-009997
Filing Date
2019-11-05
Accepted
2019-11-05 17:03:27
Documents
79
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q icpt-20190930x10qefbc2a.htm   iXBRL 10-Q 2037740
2 EX-10.1 ex-10d1.htm EX-10.1 85330
3 EX-31.1 ex-31d1.htm EX-31.1 12865
4 EX-31.2 ex-31d2.htm EX-31.2 12573
5 EX-32.1 ex-32d1.htm EX-32.1 14581
  Complete submission text file 0001558370-19-009997.txt   7454881

Data Files

Seq Description Document Type Size
6 EX-101.SCH icpt-20190930.xsd EX-101.SCH 46093
7 EX-101.CAL icpt-20190930_cal.xml EX-101.CAL 61660
8 EX-101.DEF icpt-20190930_def.xml EX-101.DEF 152295
9 EX-101.LAB icpt-20190930_lab.xml EX-101.LAB 377622
10 EX-101.PRE icpt-20190930_pre.xml EX-101.PRE 337132
33 EXTRACTED XBRL INSTANCE DOCUMENT icpt-20190930x10qefbc2a_htm.xml XML 1330504
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 191194161
SIC: 2834 Pharmaceutical Preparations